How do we change our approach to COVID with the changing face of disease?

Vasso Apostolopoulos,Jack Feehan,Vivek P. Chavda
DOI: https://doi.org/10.1080/14787210.2024.2345881
2024-04-27
Expert Review of Anti-infective Therapy
Abstract:Introduction The emergence of SARS-CoV-2 triggered a global health emergency, causing > 7 million deaths thus far. Limited early knowledge spurred swift research, treatment, and vaccine developments. Implementation of public health measures such as, lockdowns and social distancing, disrupted economies and strained healthcare. Viral mutations highlighted the need for flexible strategies and strong public health infrastructure, with global collaboration crucial for pandemic control.
pharmacology & pharmacy,infectious diseases,microbiology
What problem does this paper attempt to address?